Related Experiment Videos
[The optimal dose of 5% imiquimod for superficial basal cell carcinomas]
Presse Medicale (Paris, France : 1983)
|February 13, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Spectrum of Eosinophilic Cellulitis (Wells' Syndrome): New Insights Based on 114 Cases.
The journal of allergy and clinical immunology. In practice·2026
Pediatric Phthiriasis Palpebrarum: A French Multicentric Retrospective Study of 20 Cases.
Journal of pediatrics. Clinical practice·2026
ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype.
The Journal of experimental medicine·2026
Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.
Presse medicale (Paris, France : 1983)·2026
Artificial intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.
Presse medicale (Paris, France : 1983)·2026
AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.
Presse medicale (Paris, France : 1983)·2026
Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.
Presse medicale (Paris, France : 1983)·2026
Ethical, legal, and regulatory challenges in AI-based healthcare tools.
Presse medicale (Paris, France : 1983)·2026
Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.
Presse medicale (Paris, France : 1983)·2026
Measurement Invariance of the Brief State Rumination Inventory Across Administration Methods, National Samples, and Sex.
Journal of personality assessment·2026
Molecular Epidemiology and Phylogenetic Analysis of HTLV-1 in HIV-1-infected Patients in Tehran, Iran.
Journal of medical virology·2026
Is Insulin Resistance the Driver or the Outcome of Diabetes Mellitus? A Critical Review.
Journal of nutrition and metabolism·2026
Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.
International journal of nanomedicine·2026
Tissue Inhibitor of Metalloproteinase 2 (TIMP 2) Promotor 418 G > C Polymorphism in Non-alcoholic Fatty Liver Disease (NAFLD) Patients of Eastern States of India.
Indian journal of clinical biochemistry : IJCB·2026